Supplementary_material_pdf - FDA Reported Use of Patient Experience Data in 2018 Drug Approvals

Kieffer, Cameron M.; Miller, Alexis Reisin; Chacko, Benjamin; Robertson, Andrew S.

doi:10.25384/SAGE.9970787.v1

Cite Download Share Embed

Supplementary_material_pdf - FDA Reported Use of Patient Experience Data in 2018 Drug Approvals

2019-10-11T12:11:12Z (GMT) by Cameron M. Kieffer Alexis Reisin Miller Benjamin Chacko Andrew S. Robertson

Supplemental Material, Supplementary_material_pdf for FDA Reported Use of Patient Experience Data in 2018 Drug Approvals by Cameron M. Kieffer, Alexis Reisin Miller, Benjamin Chacko and Andrew S. Robertson in Therapeutic Innovation & Regulatory Science

Keyword(s)

Patient Focused Drug Development Regulatory Science 21st Century Cures Act Drug Applications Patient Reported Outcomes

License

CC BY-NC 4.0

Export

RefWorks

BibTeX

Endnote

DataCite

NLM

Supplementary_material_pdf - FDA Reported Use of Patient Experience Data in 2018 Drug Approvals

Categories

Keyword(s)

License

Export